Edwards Lifesciences (EW) Model Supports a Valuation of $295-$300 - Credit Suisse
Tweet Send to a Friend
Credit Suisse analyst Matt Miksic reiterated an Outperform rating and $275.00 price target on Edwards Lifesciences (NYSE: EW) on the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
